Tyrosine kinase inhibitors and gemcitabine: new treatment options in pancreatic cancer?

Tyrosine kinase inhibitors and gemcitabine: new treatment options in pancreatic cancer?

Item
http://www.wikidata.org/entity/Q36452308
Intrinsic chemoresistance to gemcitabine is associated with constitutive and laminin-induced phosphorylation of FAK in pancreatic cancer cell lines.Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer.Targeted therapies for pancreatic cancer.YM155 induces EGFR suppression in pancreatic cancer cells.Dopamine, by acting through its D2 receptor, inhibits insulin-like growth factor-I (IGF-I)-induced gastric cancer cell proliferation via up-regulation of Krüppel-like factor 4 through down-regulation of IGF-IR and AKT phosphorylationProlonged complete response following gemcitabine-erlotinib combined therapy in advanced pancreatic cancerInhibition of SIRT1 combined with gemcitabine therapy for pancreatic carcinoma.Apoptosis-inducing effect of erlotinib is potentiated by 3,3'-diindolylmethane in vitro and in vivo using an orthotopic model of pancreatic cancer.Small molecule tyrosine kinase inhibitors in pancreatic cancer.Molecular changes in pancreatic cancer.Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signaling.Discovery of genetic profiles impacting response to chemotherapy: application to gemcitabine.Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways.Review on gold nanoparticles and their applications
P2860

Tyrosine kinase inhibitors and gemcitabine: new treatment options in pancreatic cancer?

Item
http://www.wikidata.org/entity/Q36452308
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Tyrosine kinase inhibitors and gemcitabine: new treatment options in pancreatic cancer?
@ast
Tyrosine kinase inhibitors and gemcitabine: new treatment options in pancreatic cancer?
@en
type
label
Tyrosine kinase inhibitors and gemcitabine: new treatment options in pancreatic cancer?
@ast
Tyrosine kinase inhibitors and gemcitabine: new treatment options in pancreatic cancer?
@en
prefLabel
Tyrosine kinase inhibitors and gemcitabine: new treatment options in pancreatic cancer?
@ast
Tyrosine kinase inhibitors and gemcitabine: new treatment options in pancreatic cancer?
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Tyrosine kinase inhibitors and gemcitabine: new treatment options in pancreatic cancer?
@en
P2093
P304
P31
P356
10.1016/J.DRUP.2006.02.002
P433
P478
P577
P698